Magnesium and phosphorus

Lancet

Volumn 352, Issue 9125, 1998, Pages 391-396

  Weisinger, José R ^a,c   Bellorín Font, Ezequiel ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b MSAS   (Venezuela)

^c HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; CISPLATIN; CYCLOSPORIN; FOSCARNET; MAGNESIUM ION; PENTAMIDINE; PHOSPHORUS;

CRITICAL ILLNESS; EMERGENCY WARD; HUMAN; HYPERMAGNESEMIA; HYPOMAGNESEMIA; IATROGENIC DISEASE; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; ORAL DRUG ADMINISTRATION; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW; SYMPTOM;

EID: 0032145671     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)10535-9     Document Type: Review

References (36)

1. 1 Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol 1989; 256: F197-F210.
2. 2 Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997; 52: 1180-95.
3. 3 Wong ET, Rude RK, Singer FR, Shaw ST. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983; 79: 348-52.
4. 4 Elisaf M, Merkouropoulos M, Tsianos EV, Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol 1995; 9: 210-14.
5. 5 Rude RJ. Magnesium metabolism and deficiency. Endocrinol Metab Clin N Am 1993; 22: 377-95.
6. 6 Abbott LG, Rude RK. Clinical manifestations of magnesium deficiency. Mineral Electrolyte Metab 1993; 19: 314-22.
7. 7 Ryan MP. Interrelationships of magnesium and potassium homeostasis. Mineral Electrolyte Metab 1993; 19: 290-95.
8. 8 Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996; 6: 453-61.
9. 9 Al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 1994; 24: 737-52.
10. 10 Herbert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P. Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test. Crit Care Med 1997; 25: 749-55.
11. 11 McLean RM. Magnesium and its therapeutic uses: a review. Am J Med 1994; 96: 63-33376.
12. 12 Redwood SR, Taggart PI, Sutton PM, et al. Effect of magnesium on the monophasic action potential during early ischemia in the in vivo human heart. J Am Coll Cardiol 1996; 28: 1765-69.
13. 13 Clarck BA, Brown RS. Unsuspected morbid hypermagnesemia in elderly patients. Am J Nephrol 1992; 12: 336-43.
14. 14 Mehrotra R, Nolph KD, Kathuria P, Dotson L. Hypokalemic metabolic alkalosis with hypomagnesuric hypermagnesemia and severe hypocalciuria: a new syndrome? Am J Kidney Dis 1997; 29: 106-14.
15. 15 Slatopolsky E, Rutherford R, Rosenbaum, K, Martin K, Hruska. Hyperphosphatemia. Clin Nephrol 1977; 7: 138-46.
16. 16 Knochel J, Agarwal R. Hypophosphatemia and hyperphosphatemia. In: Brenner BM, ed. The kidney. Philadelphia: Saunders, 1996: 1086-133.
17. 17 Murer H, Marcovich D, Biber J. Renal and small intestine sodium-dependent symporters of phosphate and sulphate. J Exp Biol 1994; 196: 167-81.
18. 18 Bellorin-Font E, Milanes CL, Urbina D, Pernalete N, Paz-Marinez V. The regulation of sodium phosphate cotransport in the kidney. In: Puschett J, Greenberg A, eds. Diuretics, vol II. London: Elsevier Science, 1990: 427-33.
19. 19 Cheng L, Liang CT, Sacktor B. Phosphate uptake by renal membrane vesicles of rabbits adapted to high and low phosphorus diet. Am J Physiol 1983; 245: F175-80.
20. 20 Bellorin-Font E, Starosta R, Milanes CL, et al. Effect of acidosis on PTH-dependent renal adenylate cyclase in phosphorus deprivation: role of G proteins. Am J Physiol 1990; 258: F1640-49.
21. 21 Caverzasio J, Bonjour JP. Resistance to parathyroid hormone-induced inhibition of inorganic phosphate transport in opossum kidney cells cultured in low inorganic phosphate medium. J Endocrinol 1992; 134: 361-68.
22. 22 Betro MG, Pain RW. Hypophosphataemia and hyperphosphataemia in a hospital population. BMJ 1972; i: 273-76.
23. 23 King AL, Sica DA, Miller G, Pierpaoli S. Severe hyophosphatemia in a general hospitalized population. South Med J 1987; 80: 831-35.
24. 24 Stein JH, Smith WO, Ginn HE. Hyophosphatemia in acute alcoholism. Am J Med Sci 1966; 252: 78-83.
25. 25 Brautbar N, Leibovici H, Massry SG. On the mechanism of hyophosphatemia during acute hyperventilation: evidence for an increase in muscle glycolysis. Mineral Electrolyte Metab 1983; 9: 45-49.
26. 26 Drezner MK, Lobaugh Lyles KW. The pathogenesis and treatment of tumor-induced osteomalacia. In: Normal AW, Schaefer K, Herath D, Grigoleit HG, eds. Vitamin D: chemical, biochemical and clinical endocrinology of calcium metabolism. Berlin: Walter de Gruyter, 1982: 945-54.
27. 27 Clark BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol 1995; 43: 479-84.
28. 28 Bellorin-Font E, Tamayo J, Martin KJ. Uncoupling of the parathyroid hormone receptor-adenylate cyclase system of canine kidney during dietary phosphorus deprivation. Endocrinology 1984; 115: 544-49.
29. 29 Knochel JP. Hyophosphatemia and rhabdomyolysis. Am J Med 1992; 92: 455-59.
30. 30 O'Connor LR, Klein KL, Bethune JE. Effect of hyophosphatemia on myocardial performance in man. N Engl J Med 1977; 297: 901.
31. 31 Arrambide K, Toto RD. Tumor lysis syndrome. Sem Nephrol 1993; 13: 273-80.
32. 32 Hebert LA, Lemann J, Jr, Petersen JR, Lennon EJ. Studies of the mechanisms by which phosphate infusion lowers serum calcium concentration. J Clin Invest 1966; 45: 1886-90.
33. 33 Slatopolsky E, Weerts C, Thielen J, Horst R, Harter H, Martin MJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-43.
34. 34 Lopez-Hilker S, Dusso A, Raap N, Martin K, Slatopolsky E. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990; 259: F432-37.
35. 35 Slatopolsky E, Finch J, Denda M, et al. Phosphorus restriction prevents parathyroid gland growth: high phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-40.
36. 36 Weisinger JR, Mogollon A, Lander R, et al. Massive cerebral calcifications associated with increased renal phosphate reabsorption. Arch Intern Med 1986; 146: 473-77.